Breast cancer prevention and screening program
Breast Cancer Prevention and Screening Membership
NA · Assistance Publique - Hôpitaux de Paris · NCT05258539
This study is testing a new program that gives women personalized risk assessments and prevention plans to see if it helps them get screened for breast cancer more often and lowers their chances of getting the disease.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 189 (estimated) |
| Ages | 18 Years to 85 Years |
| Sex | Female |
| Sponsor | Assistance Publique - Hôpitaux de Paris (other) |
| Locations | 1 site (Paris) |
| Trial ID | NCT05258539 on ClinicalTrials.gov |
What this trial studies
The AdDePi-KS project aims to enhance breast cancer screening by providing women with personalized risk assessments and prevention consultations. Utilizing multiple breast cancer risk calculation models, the program evaluates individual risk factors and generates a tailored prevention plan. This approach encourages women to actively participate in their healthcare decisions and promotes informed discussions with healthcare providers. The study seeks to assess the effectiveness of this personalized strategy in improving screening participation and reducing breast cancer incidence.
Who should consider this trial
Good fit: Ideal candidates are women aged 18-85 who are seeking a breast cancer risk assessment at the Cancer Risk Management Platform.
Not a fit: Patients who have already been diagnosed with breast cancer or are under legal protection may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could lead to more effective breast cancer prevention and early detection strategies for women.
How similar studies have performed: Other studies have shown success with personalized risk assessment approaches in cancer prevention, indicating potential for this method.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Woman aged 18-85 years who comes to the Cancer Risk Management Platform (CRMP) for a breast cancer risk assessment * A woman who has signed an informed consent form * Woman who is a beneficiary or entitled person of a social security plan Exclusion Criteria: * Woman diagnosed with breast cancer * Woman under legal protection (guardianship, curatorship) * Woman under AME
Where this trial is running
Paris
- Hôpital Pitié Salpêtrière — Paris, France (RECRUITING)
Study contacts
- Principal investigator: Catherine UZAN, Pr — Hôpital Pitié Salpêtrière - Assistance Publique Hôpitaux de Paris
- Study coordinator: Catherine UZAN, Pr
- Email: catherine.uzan@aphp.fr
- Phone: 01 42 17 81 14
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Breast Cancer, Breast cancer, Compliance, Risk Assessment, Cancer Risk Management Platform